D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 8.95% |
| 4 | Communication Services | 6.76% |
| 5 | Financials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.75M | ﹤0.01% |
20,000
| – | – |
|
|
HES
2527
PUT
DELISTED
Hess
HES
| $1.75M | ﹤0.01% |
33,200
| – | – |
|
2528
CALL
Penumbra
PEN
$12.6B
| $1.75M | ﹤0.01% |
+10,000
| New | +$2.19M |
|
|
ADAM
2529
PUT
Adamas Trust
ADAM
$783M
| $1.75M | ﹤0.01% |
118,500
+106,000
| +848% | +$1.34M |
|
2530
CALL
Public Service Enterprise Group
PEG
$39.5B
| $1.75M | ﹤0.01% |
+30,000
| New | +$1.75M |
|
2531
Kraft Heinz
KHC
$31.1B
| $1.75M | ﹤0.01% |
50,403
-347,699
| -87% | -$11.3M |
|
2532
CALL
Ternium
TX
$9.37B
| $1.75M | ﹤0.01% |
+60,000
| New | +$1.48M |
|
|
BNFT
2533
DELISTED
Benefitfocus, Inc.
BNFT
| $1.73M | ﹤0.01% |
119,490
+24,313
| +26% | +$297K |
|
|
STFC
2534
DELISTED
State Auto Financial Corp
STFC
| $1.73M | ﹤0.01% |
97,508
+27,356
| +39% | +$415K |
|
2535
Solid Biosciences
SLDB
$777M
| $1.72M | ﹤0.01% |
15,091
-4,478
| -23% | -$283K |
|
2536
ITT
ITT
$17.7B
| $1.71M | ﹤0.01% |
22,217
-70,892
| -76% | -$4.95M |
|
|
RESI
2537
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.71M | ﹤0.01% |
105,382
-214,171
| -67% | -$2.97M |
|
2538
CALL
Sarepta Therapeutics
SRPT
$1.68B
| $1.71M | ﹤0.01% |
10,000
| – | – |
|
2539
Oaktree Specialty Lending
OCSL
$1.04B
| $1.7M | ﹤0.01% |
101,824
+13,165
| +15% | +$204K |
|
2540
RingCentral
RNG
$4.5B
| $1.7M | ﹤0.01% |
+4,485
| New | +$1.4M |
|
|
GTH
2541
DELISTED
Genetron Holdings Limited ADS
GTH
| $1.7M | ﹤0.01% |
+40,450
| New | +$1.47M |
|
2542
CALL
National Beverage
FIZZ
$2.93B
| $1.7M | ﹤0.01% |
+40,000
| New | +$1.72M |
|
2543
PUT
Synaptics
SYNA
$4.55B
| $1.7M | ﹤0.01% |
17,600
| – | – |
|
2544
PUT
Axsome Therapeutics
AXSM
$12.3B
| $1.7M | ﹤0.01% |
20,800
| – | – |
|
2545
Cadiz
CDZI
$259M
| $1.69M | ﹤0.01% |
159,067
+41,504
| +35% | +$416K |
|
2546
Rollins
ROL
$18.8B
| $1.69M | ﹤0.01% |
43,356
-525,159
| -92% | -$20.4M |
|
2547
TriNet
TNET
$2.94B
| $1.69M | ﹤0.01% |
21,010
+9,109
| +77% | +$674K |
|
2548
Marriott Vacations Worldwide
VAC
$3.4B
| $1.69M | ﹤0.01% |
12,292
-45,178
| -79% | -$5.33M |
|
2549
CALL
Trip.com Group
TCOM
$28.2B
| $1.69M | ﹤0.01% |
50,000
-40,000
| -44% | -$1.3M |
|
|
BERY
2550
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $1.69M | ﹤0.01% |
32,670
-3,158
| -9% | -$151K |
|
Similar funds
D.E. Shaw & Co's Q4 2020 Portfolio in Review
As of Q4 2020, D.E. Shaw & Co held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Snowflake worth $147M.
- D.E. Shaw & Co's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- D.E. Shaw & Co added most to Snap in Q4 2020, an estimated $362M increase.
- D.E. Shaw & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- D.E. Shaw & Co fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- D.E. Shaw & Co opened 563 new positions and closed 477 in Q4 2020.
- D.E. Shaw & Co's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.